Dr Richard Hopkins – Managing Director

Dr Hopkins is an experienced bio-pharmaceutical executive with over 11 years in corporate leadership roles with public biotechnology companies. He has an established track record in drug development of novel cancer therapies and has strong experience with corporate strategy, business development and intellectual property matters. During his career Dr Hopkins has managed and overseen several strategic alliance and licensing deals with global pharmaceutical partners.

Most recently, he was the Chief Executive Officer of PharmAust Ltd, an ASX-listed biotechnology company.  Prior to that, he was Managing Director at Phylogica Ltd, a company he co-founded in 2001 where he also held a variety of other positions including Chief Scientific Officer and Chief Operating Officer.

Richard holds a PhD in Molecular Biology, is an author on over 25 peer-reviewed publications and is an inventor on 17 patents and patent applications. Dr Hopkins currently serves as a member of the Western Australian Ausbiotech Committee.

    Watch Richard Hopkins videos here

Harry Karelis – Founder & Executive Chairman

Mr Karelis graduated from The University of Western Australia with Bachelors and Honours in Science majoring in Biochemistry and Microbiology as well as a Masters in Business Administration. He is a Fellow of the Financial Services Institute of Australia, a Fellow of the Australian Institute of Company Directors and has qualified as a Chartered Financial Analyst (CFA) from the CFA Institute in the United States.

He has in over 25 years’ diversified experience in the financial services sector including fundamental analysis, funds management and private equity investing and has acted as a director on several public and private companies in Australia, Singapore and the United Kingdom. Harry resides in Australia.

    Watch Harry Karelis videos here

Mara Gordon – Founder & Director

Mara Gordon is the Chief Research Officer of GABY, and co-founder of its subsidiary, The Oil Plant (TOP), and of Aunt Zelda’s™. She specializes in the development of cannabis treatment protocols for seriously ill patients, and is a pioneer in medicinal cannabis globally.

Previously, Mara worked as a process engineer, helping Fortune 500 companies create intelligent software. This experience has enabled her to take a detailed and scientific approach to medical cannabis.

Her pioneering work in cannabis was recently chronicled in the Ricki Lake and Abby Epstein documentary, “Weed the People”, as well as Windy Borman’s film “Mary Janes: Women of Weed”.

Mara is the Director of multiple companies in the US, Canada, and Australia, including North Bay Credit Union (NBCU). She is the co-founder of Calla Spring Wellness and Zelda Therapeutics. Mara has been the keynote speaker at numerous conferences around the globe, and holds board positions with Gabriella’s Kitchen, CannPal, Fundacion Daya, Patients Out of Time. Her wealth of experience and dedication to understanding the science behind cannabis has proven a valuable asset to GABY’s mandate of creating innovative wellness products.

    Watch Mara Gordon videos here

Jason Peterson – Founder & Director

Mr Peterson is a director, major shareholder and Head of Corporate of boutique stock broking and corporate advisory firm CPS Capital. He has more than 21 years’ experience in the financial advisory sector, which he obtained by working in both local and international stockbroking companies such as Patersons, Tolhurst and Merrill Lynch.

Mr Peterson specialises in corporate structuring, capital raisings, corporate and strategic advice to small and medium size companies and reverse takeovers. He holds a Bachelor of Commerce degree from Curtin University and a Graduate Diploma of Finance from FINSIA (Financial Services Institute of Australia)/SDIA (Securities & Derivatives Institute of Australia). He resides in Australia.

Stewart Washer – Founder & Director

Dr Washer has 20 years of CEO and board experience in medical technology, biotech and agrifood companies. He is Chairman of ASX-listed Orthocell Ltd (culturing tendon cells to repair damaged tendons), Cynata Therapeutics Ltd (developing stem cell therapies) and privately-held Minomic International Ltd (accurate non-invasive test for prostate cancer).

He has held several past senior executive roles including CEO of Celentis and managed the commercialisation of intellectual property from AgResearch in New Zealand with 650 Scientists and $130m revenues. He was also a founder of a NZ$120m New Zealand based life science fund and Venture Partner with the Swiss based Inventages Nestlé Fund. Stewart resides in Australia.